Diabetes, Vol 37, Issue 9 1260-1264, Copyright © 1988 by American Diabetes Association

ARTICLES

Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial

C Gisinger, J Jeremy, P Speiser, D Mikhailidis, P Dandona and G Schernthaner
Department of Medicine, Vienna Medical School, University of Vienna, Austria.

Vitamin E deficiency is associated with increased platelet aggregation, which can be normalized through vitamin E supplementation. In diabetes, increased platelet thromboxane A2 (TXA2) production is correlated with decreased platelet vitamin E content. We therefore investigated the effect of 400 mg DL-alpha-tocopherol acetate daily for 4 wk on ADP- and collagen-induced platelet aggregation and platelet TXA2 production in 22 type I (insulin-dependent) diabetic patients without macroangiopathy and with no or only minimal microangiopathy by a double-blind placebo-controlled crossover study. Platelet aggregation was induced in platelet-rich plasma by two or three different concentrations of ADP and collagen. TXA2 was measured by the stable spontaneous breakdown product thromboxane B2 by a specific radioimmunoassay. Whereas metabolic control remained unchanged during the study period, platelet TXA2 production was significantly (P less than .05 and P less than .01) reduced at each ADP concentration and at two of three collagen concentrations. Because increased TXA2 production of diabetic platelets is thought to play an important pathogenetic role in diabetic angiopathy, we conclude that vitamin E treatment could be beneficial with respect to platelet-vessel-wall interaction and thus might be promising for the prevention of diabetic angiopathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Dhein, A. Kabat, A. Olbrich, P. Rosen, H. Schroder, and F.-W. Mohr Effect of Chronic Treatment with Vitamin E on Endothelial Dysfunction in a Type I in Vivo Diabetes Mellitus Model and in Vitro J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 114 - 122. [Abstract] [Full Text]

				P. Mohanty, H. Ghanim, W. Hamouda, A. Aljada, R. Garg, and P. Dandona Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells Am. J. Clinical Nutrition, April 1, 2002; 75(4): 767 - 772. [Abstract] [Full Text] [PDF]

				S. Devaraj, A. V. C. Chan Jr., and I. Jialal {alpha}-Tocopherol Supplementation Decreases Plasminogen Activator Inhibitor-1 and P-Selectin Levels in Type 2 Diabetic Patients Diabetes Care, March 1, 2002; 25(3): 524 - 529. [Abstract] [Full Text] [PDF]

				W. Engelen, B. M. y Keenoy, J. Vertommen, and I. De Leeuw Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1142 - 1149. [Abstract] [Full Text] [PDF]

				S. Devaraj and I. Jialal Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications : The Effect of {alpha}-Tocopherol Supplementation Circulation, July 11, 2000; 102(2): 191 - 196. [Abstract] [Full Text] [PDF]

				J. W. Anderson, M. S. Gowri, J. Turner, L. Nichols, V. A. Diwadkar, C. K. Chow, and P. R. Oeltgen Antioxidant Supplementation Effects on Low-Density Lipoprotein Oxidation for Individuals with Type 2 Diabetes Mellitus J. Am. Coll. Nutr., October 1, 1999; 18(5): 451 - 461. [Abstract] [Full Text] [PDF]